Wolfgang Löscher
Oncology · 2004–2020
A researcher in the Science corpus: 9 papers; trusts 5 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 52 citations into it; #862 of 1,698 by trust here, #1,046 by citations
- Pediatrics, Perinatology and Child Health — 38 citations into it; #269 of 722 by trust here, #226 by citations
- Psychiatry and Mental health — 32 citations into it; #878 of 1,338 by trust here, #680 by citations
- Neurology — 15 citations into it
- Biochemistry — 8 citations into it
- Physiology — 5 citations into it; #1,868 of 2,276 by trust here, #1,782 by citations
Whom Wolfgang Löscher trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Wolfgang Löscher overall
- F. Sharom
- W. Pardridge
- Heidrun Potschka
- A. Vezzani
- Berislav Zlokovic
- R. Daneman
- Daniel S. Himmelstein
Papers from Wolfgang Löscher's perspective
Ordered by how strongly the researchers Wolfgang Löscher trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug-resistant epilepsy. (New England Journal of Medicine)
- CSF1 receptor signaling is necessary for microglia viability, which unmasks a cell that rapidly repopulates the microglia-depleted adult brain (Neuron)
- Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases (Journal of Neuroscience)
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study (JAMA Neurology)
- The gut microbiota mediates the anti-seizure effects of the ketogenic diet (Cell)
- Neuronal activity modifies DNA methylation landscape in the adult brain (Nature Neuroscience)
- Blood-brain barrier tight junction permeability and ischemic stroke. (Neurobiology of Disease)
- Blood–brain barrier structure and function and the challenges for CNS drug delivery
- Environmental standardization: cure or cause of poor reproducibility in animal experiments? (Nature Methods)
- New avenues for anti-epileptic drug discovery and development (Nature reviews. Drug discovery)
Their papers
- The neurobiology of antiepileptic drugs (2004) — 1,212 citations
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options (2020) — 780 citations
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. (2017) — 643 citations
- New avenues for anti-epileptic drug discovery and development (2013) — 616 citations
- Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. (2011) — 846 citations
- The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses (2007) — 712 citations
- Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. (2005) — 613 citations
- Drug resistance in brain diseases and the role of drug efflux transporters (2005) — 908 citations
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene family (2005) — 682 citations